期刊
RADIOTHERAPY AND ONCOLOGY
卷 149, 期 -, 页码 249-258出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2020.06.023
关键词
BMI1; CCRT; Rectal cancers; Radioresistance
资金
- Ministry of Science and Technology of Republic of China [106-2314-B-037-049-MY3, 109-2310-B-037-019, 109-2314-B-650-005-MY3]
- Kaohsiung Medical University [KMU-DK109003similar to1]
- KMU-KMUH Co-Project of Key Research [KMU-DK107013]
- KMUH [KMUH106-6M12]
- Taiwan Ministry of Health and Welfare [MOHW106-TDU-B-212-144007, MOHW107-TDU-B-212 -114020]
- E-Da Hospital, Kaohsiung, Taiwan [EDAHP107003]
- Health and Welfare surcharge of tobacco products
- Bio-Bank, Medical Research Department, E-DA Hospital
- Cancer Database of E-DA Hospital in Taiwan
- Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan
Purpose: Neoadjuvant concurrent chemoradiotherapy (CCRT) is a gold standard treatment for patients with stage II/III rectal cancer. B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) is a member of the polycomb group of proteins that are involved in regulating gene expression. High levels of BMI1 have been demonstrated to contribute to the malignant phenotypes of several cancers; however, its relevance in rectal cancer treated with CCRT is largely unknown. Methods and materials: We used two patient cohorts to address the clinical relevance of BMI1 in human cancers. In addition, HT-29 and HCT-116 cells were chosen as our in vitro models to verify the role of BMI1 in cell response to ionizing radiation. Stemness-related proteins were analyzed by western blotting and cell survival was determined using clonogenic assays. Results: BMI1 overexpression was found to significantly correlate with advanced pre-treatment nodal status (N1-N2; p < 0.001), post-treatment tumor stage (T1-T2; p = 0.015), inferior tumor regression grade (p = 0.001), and also an independent prognosis factor in 172 rectal cancer patients receiving CCRT. Serial cell-based functional examination indicated that BMI1 deficiency sensitized cells to radiation treatment by modulating the gene expression of Kruppel-like factor 4 (KLF4) and enhanced radiosensitivity in microsatellite stable (MSS) colorectal cancers. Overexpression of KLF4 partially overcame BMI1-deficiency-mediated gamma-H2AX expression after ionizing radiation exposure. Consistent with in vitro data, an analysis of an additional 30 rectal cancer tissue specimens revealed a positive correlation between BMI1 and KLF4 (p = 0.02). Conclusion: Higher levels of BMI1 are associated with poor therapeutic response and adverse outcomes in rectal cancer patients receiving CCRT. (C) 2020 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据